JANE STREET GROUP, LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$31,000
+181.8%
76,772
+150.8%
0.00%
Q3 2016$11,000
-91.1%
30,607
-91.5%
0.00%
-100.0%
Q2 2016$123,000
-67.0%
362,162
-48.4%
0.00%
-50.0%
Q1 2016$373,000
-76.0%
701,579
-44.4%
0.00%
-80.0%
Q4 2015$1,553,000
+437.4%
1,262,761
+537.7%
0.01%
+400.0%
Q3 2015$289,000
-92.0%
198,031
-89.4%
0.00%
-91.3%
Q2 2015$3,629,000
+274.1%
1,860,910
+247.3%
0.02%
+187.5%
Q1 2015$970,000
-60.7%
535,751
-48.7%
0.01%
-57.9%
Q4 2014$2,467,000
-29.0%
1,045,362
-27.2%
0.02%
-45.7%
Q3 2014$3,473,000
+22.2%
1,434,975
+41.9%
0.04%
-2.8%
Q2 2014$2,841,0001,011,2350.04%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2017.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders